We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$27.9B
AUM Growth
+$6.35B
Cap. Flow
+$3.76B
Cap. Flow %
13.48%
Top 10 Hldgs %
12.67%
Holding
2,368
New
371
Increased
836
Reduced
637
Closed
381

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$228M
2
KO icon
Coca-Cola
KO
+$167M
3
AAPL icon
Apple
AAPL
+$131M
4
MDLZ icon
Mondelez International
MDLZ
+$121M
5
UNH icon
UnitedHealth
UNH
+$116M

Sector Composition

Rank Sector Weight
1 Technology 19.75%
2 Healthcare 15.02%
3 Consumer Discretionary 12.4%
4 Financials 11.54%
5 Industrials 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNGR icon
1776
FingerMotion
FNGR
$16.2M
$113K ﹤0.01%
+40,148
New +$219K
ESPR
1777
DELISTED
Esperion Therapeutics
ESPR
$113K ﹤0.01%
+18,100
New +$129K
VOR icon
1778
Vor Biopharma
VOR
$1.04B
$113K ﹤0.01%
+848
New +$83.9K
EVTL.WS
1779
DELISTED
Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share
EVTL.WS
$111K ﹤0.01%
354,636
ANNX icon
1780
Annexon
ANNX
$855M
$111K ﹤0.01%
+21,377
New +$117K
AMRX icon
1781
Amneal Pharmaceuticals
AMRX
$5.72B
$110K ﹤0.01%
55,151
+29,448
+115% +$66K
KVHI icon
1782
KVH Industries
KVHI
$177M
$110K ﹤0.01%
+10,717
New +$109K
PAYA
1783
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$109K ﹤0.01%
13,900
HAYW icon
1784
Hayward Holdings
HAYW
$3.13B
$109K ﹤0.01%
+11,611
New +$108K
ASPS icon
1785
Altisource Portfolio Solutions
ASPS
$65.4M
$109K ﹤0.01%
+1,440
New +$149K
DBI icon
1786
Designer Brands
DBI
$277M
$108K ﹤0.01%
+11,008
New +$148K
KULR icon
1787
KULR Technology Group
KULR
$117M
$107K ﹤0.01%
+11,120
New +$137K
YPF icon
1788
YPF
YPF
$20.2B
$107K ﹤0.01%
11,612
-16,902
-59% -$130K
CCO icon
1789
Clear Channel Outdoor Holdings
CCO
$1.23B
$105K ﹤0.01%
100,448
ABUS icon
1790
Arbutus Biopharma
ABUS
$865M
$105K ﹤0.01%
44,900
-42,346
-49% -$101K
OPEN icon
1791
Opendoor
OPEN
$3.7B
$103K ﹤0.01%
92,021
-573,436
-86% -$1.1M
FHTX icon
1792
Foghorn Therapeutics
FHTX
$285M
$101K ﹤0.01%
+15,855
New +$120K
ARQ icon
1793
Arq
ARQ
$86.9M
$99.4K ﹤0.01%
40,894
+26,794
+190% +$72.9K
SEER icon
1794
Seer Inc
SEER
$108M
$98.2K ﹤0.01%
+16,929
New +$114K
SMMT icon
1795
Summit Therapeutics
SMMT
$10.9B
$98.1K ﹤0.01%
23,092
+7,373
+47% +$13.4K
CNTY icon
1796
Century Casinos
CNTY
$32.9M
$97.2K ﹤0.01%
+13,833
New +$101K
ASUR icon
1797
Asure Software
ASUR
$220M
$95.5K ﹤0.01%
+10,224
New +$72.9K
NGVC icon
1798
Vitamin Cottage Natural Grocers
NGVC
$691M
$95.3K ﹤0.01%
+10,429
New +$110K
LRMR icon
1799
Larimar Therapeutics
LRMR
$416M
$94.8K ﹤0.01%
+22,956
New +$78.4K
NDLS icon
1800
Noodles & Co
NDLS
$90.5M
$94.2K ﹤0.01%
+2,144
New +$94K

Similar funds

Man Group's Q4 2022 Portfolio in Review

As of Q4 2022, Man Group held 2,368 positions worth $27.9B, up 29% from $21.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Man Group deployed $3.76B of net new capital in Q4 2022, opening 371 new positions and adding to 836 existing holdings. Its largest new stake was Textron: 910,556 shares worth $64.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Public Storage, an estimated $80.2M trimmed.

  • Man Group's largest Q4 2022 buy was Textron: 910,556 shares worth $64.5M.
  • Man Group added most to PepsiCo in Q4 2022, an estimated $228M increase.
  • Man Group's biggest Q4 2022 reduction was Public Storage, cutting an estimated $80.2M.
  • Man Group fully exited ZENDESK INC in Q4 2022, selling an estimated $69.1M.
  • Man Group's ten largest holdings make up 13% of its $27.9B portfolio in Q4 2022.
  • Man Group opened 371 new positions and closed 381 in Q4 2022.
  • Man Group's portfolio value rose 29% quarter-over-quarter to $27.9B.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.